Where does Matthew Meyerson practice?

Matthew Meyerson is affiliated with Harvard University in United States.

What is Matthew Meyerson's H-index?

Matthew Meyerson has an H-index of 366, placing them in the top 0.01% of medical professionals worldwide.

What is Matthew Meyerson's medical specialty?

Matthew Meyerson specializes in Cancer Genomics.

Is Matthew Meyerson verified by MDRPedia?

Yes, Matthew Meyerson is a verified TITAN tier physician on MDRPedia, the global authority for medical reputation.

Matthew Meyerson — MDRPedia

Top 0.01% — Titan Top 100 (#26)

Matthew Meyerson

Cancer Genomics

United States

366 H-Index

7,001 Total Impact

Share or Embed Profile

Profile URL

Quick Share

Embed Style

Minimal link badge for your website

<a href="https://mdrpedia.com/doctors/matthew-meyerson" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:8px 16px;background:#1a1a2e;border:1px solid rgba(255,255,255,0.1);border-radius:8px;text-decoration:none;color:#fff;font-family:system-ui,sans-serif;font-size:14px;"><span style="color:#ffd700;">●</span>Matthew Meyerson — MDRPedia</a>

Preview:

● Matthew Meyerson — MDRPedia

Copied!

Overview

Matthew Meyerson is a cancer genomics specialist with an H-index of 366 at Harvard University (Faculty). Has been published in Nature, Science, Cancer Cell. Based in United States.

Biography

Matthew Langer Meyerson is an American pathologist and the Charles A. Dana Chair in Human Cancer Genetics at the Dana-Farber Cancer Institute. He is also director of the Center for Cancer Genomics at the Dana-Farber Cancer Institute, and the Director of Cancer Genomics at the Broad Institute of MIT and Harvard.

Affiliations & Institutions

Harvard University

Faculty

Research Impact

5 Publications

0 Total Citations

Published In

Nat GenetNat MedCell

Areas of Expertise

Medical Specialties

Cancer Genomics

Titan

Bert Vogelstein , MD

Cancer Genomics

Unknown

494200y

Arul Chinnaiyan , MD

Cancer Genomics

Global

000y

Matthew Meyerson

Share or Embed Profile

Overview

Biography

Affiliations & Institutions

Harvard University

Research Impact

Published In

Key Publications

Mutational processes shape the landscape of TP53 mutations in human cancer.

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.

Oncogenic Signaling Pathways in The Cancer Genome Atlas.

The somatic genomic landscape of glioblastoma.

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.

Areas of Expertise

Medical Specialties

Related Specialists

Bert Vogelstein , MD

Arul Chinnaiyan , MD